Fig. 2From: Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trialsForest plot for MACE and all-cause mortality of anti-diabetic agents compared with sulfonylurea (individual and categorized agents). Treatments are ranked by surface under the cumulative ranking (SUCRA) values. OR odds ratio, CrI credibility intervalBack to article page